ARUP Laboratories Selects Bruker’s MALDI Biotyper Solution for Rapid Microbial Identification by Proteomic Fingerprinting
07 September 2010 - 9:00PM
Business Wire
Bruker Daltonics today announced that ARUP Laboratories has
selected and installed the Bruker MALDI Biotyper system as their
next-generation rapid microbial identification system. The MALDI
Biotyper has obtained the IVD-CE Mark, and is currently for
Research Use Only (RUO) outside of the European Union.
The MALDI Biotyper is a MALDI-TOF mass spectrometry based
platform for rapidly identifying bacteria, yeasts and fungi. Its
carefully curated database includes quality-controlled entries of
over 3,700 strains from about 2,000 well-characterized microbial
species. Starting from a cultured colony, identification is
performed by matching the measured protein fingerprint against the
proprietary MALDI Biotyper database. Including the database search,
automatic identification can be performed in minutes. Multiple
colonies can be spotted on a single target, and about 30-60
identifications can be performed every hour. The MALDI Biotyper
offers rapid time-to-result, high specificity, very low false
positive rates, low operational costs, and low technical barriers
for new operators.
Bruker has installed over 150 MALDI Biotyper systems worldwide
in routine laboratories for microbiology, and the MALDI Biotyper is
rapidly becoming a new standard for robust, rapid microbial
identification. ARUP plans to use the MALDI Biotyper for microbial
identifications currently performed by DNA sequencing, and expects
to see improvements in time to result, workflow and consumables
costs. ARUP is also investigating the use of the MALDI Biotyper to
replace phenotypic methods for identification, and plans to
collaborate with Bruker to develop additional tests on the MALDI
Biotyper.
Sherrie Perkins, MD, PhD, ARUP’s chief medical officer and
director of laboratories stated: “We are excited to have access to
this new technology. We hope the equipment will improve our
microbiology services to clients, and we look forward to a fruitful
collaboration with Bruker.”
Dr. Gary Kruppa, Vice President for Business Development of
Bruker Daltonics said: “We have enjoyed working with ARUP, and we
are very pleased they have selected the MALDI Biotyper for use both
in their research and their routine microbial identification
production facility. We look forward to continuing to work with
ARUP on further applications of the MALDI Biotyper.”
ARUP is a reference laboratory owned by the University of
Utah.
ABOUT BRUKER DALTONICS
For more information about Bruker Daltonics and Bruker
Corporation (NASDAQ: BRKR), please visit www.bdal.com and
www.bruker.com.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6417487&lang=en
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024